To access courses on this site, please log in to an existing account or register a new account to get started.
Alteplase- and Tenecteplase-Related Errors and
Risk Mitigation Strategies
A Study of Event Reports From 52 Hospitals
TARGET AUDIENCE: Physicians, pharmacists, nurses
APPROXIMATE COMPLETION TIME: 30 minutes
EDUCATION CREDITS: Pennsylvania nursing 0.5 hour
JOURNAL ARTICLE DESCRIPTION
Alteplase and tenecteplase are thrombolytic agents used to treat patients with acute ischemic stroke (AIS). Despite the convenient bolus dosing of tenecteplase, its off-label use for AIS creates new patient safety challenges that are understudied.
COURSE OBJECTIVES
- Understand medication error, event type, associated factor, and stage of the medication-use process as defined in the study
- Compare and contrast alteplase- and tenecteplase-related safety events associated with the different stages of the medication-use process
- Implement various risk mitigation strategies to reduce errors associated with the use of alteplase and tenecteplase in the treatment of AIS
Complete the quiz and brief evaluation at the end of the educational content . With a quiz score of 80% or greater, you will be awarded a continuing education certificate. THANK YOU!
Note: None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.